Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.22.1
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]    
NET REVENUE $ 35,341 $ 29,768
Direct operating costs 22,673 18,060
Selling and marketing 2,384 1,890
General and administrative 5,585 5,624
Research and development 985 2,026
Change in contingent consideration (600)
Depreciation and amortization 2,940 2,831
Impairment and unoccupied lease charges 158 1,018
Total operating expenses 34,125 31,449
Operating income (loss) 1,216 (1,681)
Healthcare IT [Member]    
Segment Reporting Information [Line Items]    
NET REVENUE 32,153 27,033
Direct operating costs 20,011 15,987
Selling and marketing 2,376 1,882
General and administrative 3,400 3,426
Research and development 985 2,026
Change in contingent consideration (600)  
Depreciation and amortization 2,852 2,749
Impairment and unoccupied lease charges 158 1,018
Total operating expenses 29,182 27,088
Operating income (loss) 2,971 (55)
Medical Practice Management [Member]    
Segment Reporting Information [Line Items]    
NET REVENUE 3,188 2,735
Direct operating costs 2,662 2,073
Selling and marketing 8 8
General and administrative 437 520
Research and development
Change in contingent consideration  
Depreciation and amortization 88 82
Impairment and unoccupied lease charges
Total operating expenses 3,195 2,683
Operating income (loss) (7) 52
Unallocated Corporate Expenses [Member]    
Segment Reporting Information [Line Items]    
NET REVENUE
Direct operating costs
Selling and marketing
General and administrative 1,748 1,678
Research and development
Change in contingent consideration  
Depreciation and amortization
Impairment and unoccupied lease charges
Total operating expenses 1,748 1,678
Operating income (loss) $ (1,748) $ (1,678)